In addition, we confirmed that the mRNA expression of COL1A1 and TGF-b, factors affecting the liver fibrosis process, was upregulated by THA treatment but decreased by Rh2 treatment (Figure 4I,J). The gene discussed is TGFB1; the disease is medical procedure.